日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

更正:Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy

中枢神经系统国际预后指数在接受含利妥昔单抗化疗免疫疗法治疗的原发性纵隔大B细胞淋巴瘤患者中的应用价值

Yang, Jiayu; Hayden, Anna R; Villa, Diego; Jiang, Aixiang; Gerrie, Alina S; Venner, Christopher P; Farinha, Pedro; Scott, David W; Sehn, Laurie H; Savage, Kerry J

Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq

单细胞RNA测序揭示了诊断期和复发期经典霍奇金淋巴瘤的肿瘤微环境差异

Yin, Yifan; Rai, Shinya; Jiang, Aixiang; Xu, Alexander; O'Brien, Luke; Telenius, Adèle; Delabie, Jan; Chong, Lauren; Hung, Stacy; Merchant, Akil; Scott, David W; Savage, Kerry J; Aoki, Tomohiro; Steidl, Christian

Retreatment with R-CHOP-like therapy in patients with late relapse of diffuse large B-cell lymphoma

对晚期复发的弥漫性大B细胞淋巴瘤患者采用R-CHOP样疗法进行再治疗

Champagne, Jean-Nicolas; Villa, Diego; Gerrie, Alina S; Venner, Christopher P; Slack, Graham W; Farinha, Pedro; Craig, Jeffrey W; Hilton, Laura K; Savage, Kerry J; Scott, David W; Sehn, Laurie H

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology

在具有 MYC/BCL2 重排的高级别 B 细胞淋巴瘤、DLBCL 形态学中,广泛推广剂量调整后的 EPOCH-R 方案

Alduaij, Waleed; Sehn, Laurie H; Champagne, Jean-Nicolas; Collinge, Brett; Ben-Neriah, Susana; Jiang, Aixiang; Hilton, Laura K; Boyle, Merrill; Meissner, Barbara; Slack, Graham W; Farinha, Pedro; Craig, Jeffrey W; Savage, Kerry J; Villa, Diego; Gerrie, Alina S; Freeman, Ciara L; Mungall, Andrew J; Steidl, Christian; Scott, David W

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma

纳武利尤单抗联合维布妥昔单抗治疗复发/难治性弥漫性大B细胞淋巴瘤

Johnson, Nathalie A; Zinzani, Pier Luigi; Domingo-Domenech, Eva; Brody, Joshua; Kline, Justin; Shah, Bijal Dinesh; Mehta, Amitkumar Nitinkumar; Ghesquieres, Herve; Savage, Kerry J; Barr, Paul M; Santoro, Armando; Ferrari, Silvia; Cunningham, David; Collins, Graham P; Fanale, Michelle; Krajewski, Jennifer; Akyol, Alev; Crowe, Russell; Wen, Rachael; Kuruvilla, John

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma

纳武利尤单抗联合多柔比星、长春碱、达卡巴嗪作为一线疗法治疗老年霍奇金淋巴瘤患者的II期临床试验

Torka, Pallawi; Feldman, Tatyana; Savage, Kerry J; Ganesan, Nivetha; Drill, Esther; Hancock, Helen; Davey, Theresa; Perez, Leslie; Capadona, Charisse; Subzwari, Sarima; Galasso, Natasha; Yang, Jinshu; Post, Michelle; Boardman, Alexander; Caron, Philip; David, Kevin; Epstein-Peterson, Zachary; Falchi, Lorenzo; Ghione, Paola; Hamlin, Paul; Horwitz, Steven M; Intlekofer, Andrew M; Johnson, William; Kumar, Anita; Lue, Jennifer; Noy, Ariela; Owens, Colette; Palomba, M Lia; Salles, Gilles A; Steiner, Raphael; Stuver, Robert; Vardhana, Santosha; Yahalom, Joachim; Dogan, Ahmet; Zelenetz, Andrew D; Schöder, Heiko; Moskowitz, Alison J

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022

在 RELATIVITY-022 研究中,Nivolumab 联合 relatlimab 用于治疗复发或进展性 B 细胞恶性肿瘤患者

Gopal, Ajay K; Armand, Philippe; Neelapu, Sattva S; Bartlett, Nancy L; Spurgeon, Stephen E; Kuruvilla, John; Savage, Kerry J; Leonard, John P; Gelb, Arnold B; Ahmed, Nasir; Dong, Shiqi; Bathena, Sai Praneeth; Suryawanshi, Rasika; Wu, Jenny Qun; Wang, Sheen; Gladstone, Douglas E

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study

高级别B细胞淋巴瘤,未另行说明:一项LLMPP研究

Collinge, Brett; Hilton, Laura K; Wong, Jasper; Alduaij, Waleed; Ben-Neriah, Susana; Slack, Graham W; Farinha, Pedro; Boyle, Merrill; Meissner, Barbara; Cook, James R; Ott, German; Rosenwald, Andreas; Campo, Elias; Amador, Catalina; Greiner, Timothy C; Raess, Philipp W; Song, Joo Y; Inghirami, Giorgio; Ondrejka, Sarah L; Jaffe, Elaine S; Weisenburger, Dennis D; Chan, Wing C; Holte, Harald; Beiske, Klaus; Fu, Kai; Delabie, Jan; Pittaluga, Stefania; Iqbal, Javeed; Wright, George; Savage, Kerry J; Mungall, Andrew J; Staudt, Louis M; Steidl, Christian; Feldman, Andrew L; Morin, Ryan D; Rimsza, Lisa M; Scott, David W